Abstract | BACKGROUND AND PURPOSE: METHODS: RESULTS: CONCLUSIONS:
Thrombectomy in non- vitamin K antagonist oral anticoagulant patients seems safe although a comparatively high rate of asymptomatic hemorrhagic transformation was noted. Confirmation in larger prospective controlled cohorts is necessary. CLINICAL TRIAL REGISTRATION: URL: http://www.clinicaltrials.gov. Unique identifier: NCT01850797.
|
Authors | Jan C Purrucker, Marcel Wolf, Kirsten Haas, Timolaos Rizos, Shujah Khan, Rainer Dziewas, Christoph Kleinschnitz, Andreas Binder, Klaus Gröschel, Michael G Hennerici, Kyriakos Lobotesis, Sven Poli, Günter Seidel, Tobias Neumann-Haefelin, Peter A Ringleb, Peter U Heuschmann, Roland Veltkamp |
Journal | Stroke
(Stroke)
Vol. 47
Issue 4
Pg. 1127-30
(Apr 2016)
ISSN: 1524-4628 [Electronic] United States |
PMID | 26931156
(Publication Type: Journal Article)
|
Copyright | © 2016 American Heart Association, Inc. |
Chemical References |
|
Topics |
- Aged
- Anticoagulants
(therapeutic use)
- Brain Ischemia
(drug therapy, therapy)
- Endovascular Procedures
(adverse effects, methods)
- Female
- Humans
- Intracranial Hemorrhages
(etiology)
- Male
- Prospective Studies
- Stroke
(drug therapy, therapy)
- Thrombectomy
(adverse effects, methods)
- Thrombolytic Therapy
- Treatment Outcome
|